DLBCL could be classified by the activity of (i) the B-cell receptor (BCR) signaling, (ii) the inflammatory/host response genes, and of (iii) the mitochondrial oxidative phosphorylation (OxPhos) genes. This evidence concerns the gene BCR and diffuse large B-cell lymphoma.